# Compass Therapeutics, Inc.: Form 8-K, filed Mar 10, 2023

- Company: [Compass Therapeutics, Inc.](/companies/cmpx.md) (CIK 1738021)
- Form: 8-K
- Filed: 2023-03-10
- Accepted by EDGAR: Mar 10, 2023, 16:56 ET
- Period: 2023-03-10
- Accession: 0001171843-23-001585
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1738021/000117184323001585/f8k_031023.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1738021/000117184323001585/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1738021/000117184323001585/f8k_031023.htm

Filed Mar 10, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-001585. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.